HMT Named Top 10 CRO in Europe

HMT is granted patent for MDD biomarker in the EU

HMT enters strategic partnership in China

HMT publishes on first diagnostic biomarker for MDD

HMT to develop clinical assay for MDD biomarker

HMT collaboration with NIH/NIA to study Alzheimer’s

HMT develops assay kit for depression biomarker

HMT joins NIH OSTR Subsidy Program

HMT Names Alex Buko as VP of Biomarker Development

HMT diagnostic biomarker for depression

HMT Opens US Office